Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Impact of Oxypurinol in Patients With Symptomatic Heart Failure | Synapse

May 5, 2026

View Full Paper

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

Joshua M. HareHeart Failure & Transplant BMBrian Mangalh2med (United States)JBJoanne BrownCambridge University Hospitals NHS Foundation Trust

Key Points

Key points are not available for this paper at this time.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Hare et al. (Sun,) studied this question.

synapsesocial.com/papers/69fa5ec37d441863e5502420 https://doi.org/https://doi.org/10.1016/j.jacc.2008.01.068

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure2004 · 58 citations
2Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure2001 · 391 citations
3Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity2002 · 561 citations
4Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy2001 · 437 citations
5Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure2005 · 89 citations